ArticleNPJ precision oncology2026

Clinical validation of a tissue-agnostic genome-wide methylome enrichment assay to monitor response to pembrolizumab.

Eric Y Stutheit-Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.